Subscribe to Newsletter

Bioprocessing - Upstream & Downstream

Manufacture Bioprocessing - Upstream & Downstream

Single-Pass Promise

| Torsten Bisschop, Matteo Costioli

When EMD Serono wanted to increase drug production, they found that their manufacturing process did not have the required capacity.

Manufacture Bioprocessing - Single Use Systems

Strengthening Supply Chains with MilliporeSigma

| Sponsored by MilliporeSigma

As a leading partner and supplier to the industry, MilliporeSigma continues to strengthen and enhance its supply chain capabilities.

Business & Regulation Small Molecules

And for 2020...

| Stephanie Vine

Nominations are now open for The Medicine Maker 2020 Power List.

Manufacture Bioprocessing - Upstream & Downstream

Turning up the Heat for Virus Removal (ms)

| Sponsored by MilliporeSigma

Viral contamination can have devastating effects. But innovations upstream can help prevent that.

Manufacture Contract Manufacturing Services

Perks and Pitfalls of Antibody Drug Conjugates

| Stephanie Vine

ADCs have suffered a few setbacks over the years, but interest in their therapeutic potential – particularly against cancer – remains high.

Manufacture Bioprocessing - Upstream & Downstream

Built on Innovation

| Sponsored by Schott

Innovation in glass continues to be a key enabler for allowing pharma manufacturers to make better, safer products for patients.

Manufacture Bioprocessing - Upstream & Downstream

The Upstream/Downstream Process Balancing Act

| Serena Fries Smith, Hunter Malanson

Early collaboration and open communication between upstream and downstream are crucial to ensure a consistent end-to-end bioprocess.

Manufacture Bioprocessing - Upstream & Downstream

Trials of a Medicine Maker

Gene is in charge of seed train duty! But the reality doesn’t quite live up to his expectations…

Manufacture Advanced Medicine

Trials of a Medicine Maker

What lies ahead for Gene and Eva in 2019? Cell and gene therapies!

Manufacture Technology and Equipment

Back to Nature

| Bill Whitford

It’s time for pharma to leave behind the highly energy-dependent and inflexible processes of the 20th century. Let’s “biologicalize” manufacturing.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register